When this lesion was seen on the face of a 54-year-old farm worker, cutaneous melanoma was the immediate concern. Accordingly, a full-thickness excisional biopsy was performed. (Curettage and shave biopsy are contraindicated for a suspected melanoma.)
When this lesion was seen on the face of a 54-year-old farm worker, cutaneous melanoma was the immediate concern. Accordingly, a full-thickness excisional biopsy was performed. (Curettage and shave biopsy are contraindicated for a suspected melanoma.) Fortunately, the neoplasm proved to be a pigmented basal cell carcinoma (BCC), a rare form that has no greater tendency toward malignancy than nonpigmented types.
Dr Luis Lomeli of Rancho Cucamonga, Calif, comments that there are at least 5 variants of BCC, which account for more than 75% of skin cancers. These tumors may spread deeply or widely into adjacent structures. The morphea-like and keratotic types are 2 of the more aggressive forms. In addition to complete excision, other treatment for histologically proven, nonaggressive BCC includes cryosurgery or electrodesiccation with curettage.
Because patients who have had one BCC are likely to have others, and because the growths may recur within 10 years, long-term follow-up is essential. Warn patients to reduce future exposure to UV irradiation by wearing appropriate clothing and using sunscreens with a sun-protective factor greater than 15.
Atopic Dermatitis: The Pipeline and Clinical Approaches That Could Transform the Standard of Care
September 24th 2025Patient Care tapped the rich trove of research and expert perspectives from the Revolutionizing Atopic Dermatitis 2025 conference to create a snapshot of the AD care of the future.